A 2025 study in Biomolecules found that NNMT inhibitor treatment "reduces body weight, white adipose tissue mass, total cholesterol, and adipocyte size in obese mice." These changes suggest cardiovascular benefit beyond simple weight loss
We chose to exclude those because weve seen enough conflicting evidence around the former and too sparse a collection of evidence around the latter that it seemed wiser at this time, for both safety and efficacy reasons, to leave them out
37,38 In a 36-week phase II study, once-weekly injectable amycretin produced a mean reduction in body weight of ~22%, exceeding the weight loss observed with currently available GLP-1 RAs
Each form suits different lifestyles and goals
We aim to support better health outcomes by supplying a wide range of pharmaceutical tablets and capsules for various medical conditions.